The human tau transgene expression provides a pre-conditioned medium that facilitates spreading of tau pathology while remaining faithful to what is observed in human AD by using human AD PHF tau extracts and non-mutant transgenic tau. The gene discussed is MAPT; the disease is Alzheimer disease.